# LINGO1

## Overview
LINGO1 is a gene that encodes the protein leucine rich repeat and Ig domain containing 1, which is a transmembrane protein involved in the regulation of neuronal development and myelination within the central nervous system (CNS). The protein is characterized by its leucine-rich repeat (LRR) motifs and immunoglobulin-like (Ig) domain, which facilitate protein-protein interactions essential for its function (Guillemain2020LINGO; Mi2008LINGO1). LINGO1 is a critical component of the Nogo-66 receptor complex, where it acts as a negative regulator of axon growth and oligodendrocyte differentiation, thereby influencing myelination processes (Shao2017LINGO1; Mi2004LINGO1). The protein's interactions with other receptors and signaling pathways underscore its significance in neurodevelopment and its potential as a therapeutic target for demyelinating diseases and various neurological disorders (Shao2017LINGO1; Andrews2015A).

## Structure
LINGO1 is a transmembrane protein encoded by the LINGO1 gene, consisting of 620 amino acids (Guillemain2020LINGO; Ansar2018Biallelic). The protein features a large extracellular region with 12 leucine-rich repeat (LRR) motifs and one immunoglobulin-like (Ig) domain, which are crucial for protein-protein interactions (Guillemain2020LINGO; Mi2008LINGO1). The LRR motifs form a horseshoe-shaped solenoid structure, while the Ig domain contributes to stability and binding specificity (Llorens2008Developmental). 

LINGO1 also includes a transmembrane domain and a short cytoplasmic tail, which contains a canonical epidermal growth factor receptor-like tyrosine phosphorylation site (Mi2008LINGO1; Mi2004LINGO1). The protein is known to form stable tetramers in its extracellular part, which may serve as a scaffold for binding platforms, facilitating the assembly of receptor complexes (Guillemain2020LINGO; Andrews2015A). 

Post-translational modifications such as glycosylation are important for LINGO1's function, with specific residues like Asn264 being potential glycosylation sites (Ansar2018Biallelic). LINGO1 has at least 12 different isoforms in humans, which differ in their 5′ untranslated regions but share identical coding exons (Ansar2018Biallelic).

## Function
LINGO1 (leucine rich repeat and Ig domain containing 1) is a protein that plays a critical role in the central nervous system (CNS) by regulating neuronal development and myelination. It is a component of the Nogo-66 receptor complex, interacting with NgR1 and p75 to form a receptor complex that modulates RhoA activation, which is crucial for controlling axon growth and extension (Mi2004LINGO1). LINGO1 acts as a negative regulator of oligodendrocyte differentiation and myelination, processes essential for neurodevelopment. It inhibits the differentiation of oligodendrocyte precursor cells (OPCs) and the formation of myelin, a protective sheath around nerve fibers (Shao2017LINGO1; Lee2007NGF).

The protein is primarily active in the cell membrane and is involved in protein-protein interactions, as indicated by its leucine-rich repeat motifs, immunoglobulin domain, and transmembrane domain (Mi2004LINGO1). LINGO1's inhibition of myelination is mediated through its interaction with the cytoplasmic gelsolin (cGSN) signaling pathway, which regulates actin dynamics necessary for OPC differentiation (Shao2017LINGO1). Inhibition of LINGO1 can promote oligodendrocyte differentiation and myelination, suggesting potential therapeutic applications for demyelinating diseases (Mi2008LINGO1).

## Clinical Significance
The LINGO1 gene is implicated in a variety of neurological and psychiatric disorders due to its role as a negative regulator of myelination and neurite outgrowth. Alterations in LINGO1 expression or mutations can contribute to conditions such as essential tremor and Parkinson's disease. Genome-wide association studies have identified specific single nucleotide polymorphisms (SNPs) in LINGO1, such as rs9652490 and rs11856808, that are linked to essential tremor, with some studies suggesting a potential association with Parkinson's disease, particularly in subtypes with predominant tremor (Lorenzo‐Betancor2011LINGO1; Andrews2015A).

In multiple sclerosis, LINGO1 expression is decreased in certain brain regions, and its antagonism has shown promise in promoting remyelination and oligodendrocyte differentiation in animal models. This has led to the development of therapeutic agents like BIIB033, a monoclonal antibody targeting LINGO1, which has shown safety and efficacy in early clinical trials (Andrews2015A).

LINGO1 is also involved in Alzheimer's disease, where it interacts with amyloid precursor protein, potentially increasing amyloid-β production and contributing to neurodegenerative processes (Andrews2015A). Its role in inhibiting the EGFR/PI3-K/Akt signaling pathway further implicates it in conditions like schizophrenia and depression (Andrews2015A).

## Interactions
LINGO1 is a protein that participates in several key interactions within the central nervous system. It is a component of the Nogo-66 receptor complex, where it interacts with the Nogo receptor (NgR1) and the p75 neurotrophin receptor to form a ternary complex. This complex is crucial for mediating the inhibitory effects on axon regeneration and neurite outgrowth (Mi2004LINGO1). LINGO1 also interacts with TROY, another receptor that can substitute for p75 in the receptor complex (Zhang2009LINGO1).

In addition to its role in the Nogo receptor complex, LINGO1 interacts with the serine-threonine kinase WNK1. This interaction is enhanced by Nogo66 treatment and plays a role in regulating neurite extension by affecting RhoA activation (Zhang2009LINGO1). LINGO1 also interacts with the cytoplasmic gelsolin (cGSN) signaling pathway, which is involved in actin dynamics crucial for oligodendrocyte differentiation and myelination (Shao2017LINGO1).

LINGO1 can form homotypic interactions and heterodimers with its homologs LINGO-2, LINGO-3, and LINGO-4, which may regulate its function (Guillemain2020LINGO). These interactions highlight LINGO1's role in modulating neuronal development and response to myelin-associated inhibitors.


## References


[1. (Llorens2008Developmental) Franc Llorens, Vanesa Gil, Susana Iraola, Laura Carim‐Todd, Eulàlia Martí, Xavier Estivill, Eduardo Soriano, José Antonio del Rio, and Lauro Sumoy. Developmental analysis of lingo‐1/lern1 protein expression in the mouse brain: interaction of its intracellular domain with myt1l. Developmental Neurobiology, 68(4):521–541, January 2008. URL: http://dx.doi.org/10.1002/dneu.20607, doi:10.1002/dneu.20607. This article has 40 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/dneu.20607)

[2. (Ansar2018Biallelic) Muhammad Ansar, Saima Riazuddin, Muhammad Tahir Sarwar, Periklis Makrythanasis, Sohail Aziz Paracha, Zafar Iqbal, Jamshed Khan, Muhammad Zaman Assir, Mureed Hussain, Attia Razzaq, Daniel Lôpo Polla, Abid Sohail Taj, Asbjørn Holmgren, Naila Batool, Doriana Misceo, Justyna Iwaszkiewicz, Arjan P.M. de Brouwer, Michel Guipponi, Sylviane Hanquinet, Vincent Zoete, Federico A. Santoni, Eirik Frengen, Jawad Ahmed, Sheikh Riazuddin, Hans van Bokhoven, and Stylianos E. Antonarakis. Biallelic variants in lingo1 are associated with autosomal recessive intellectual disability, microcephaly, speech and motor delay. Genetics in Medicine, 20(7):778–784, July 2018. URL: http://dx.doi.org/10.1038/gim.2017.113, doi:10.1038/gim.2017.113. This article has 21 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/gim.2017.113)

[3. (Zhang2009LINGO1) Zhaohuan Zhang, Xiaohui Xu, Yong Zhang, Jianfeng Zhou, Zhongwang Yu, and Cheng He. Lingo-1 interacts with wnk1 to regulate nogo-induced inhibition of neurite extension. Journal of Biological Chemistry, 284(23):15717–15728, June 2009. URL: http://dx.doi.org/10.1074/jbc.m808751200, doi:10.1074/jbc.m808751200. This article has 46 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m808751200)

[4. (Lorenzo‐Betancor2011LINGO1) Oswaldo Lorenzo‐Betancor, Lluís Samaranch, Elena García‐Martín, Sebastián Cervantes, José A.G. Agúndez, Félix J. Jiménez‐Jiménez, Hortensia Alonso‐Navarro, Antonio Luengo, Francisco Coria, Elena Lorenzo, Jaione Irigoyen, and Pau Pastor. Lingo1 gene analysis in parkinson’s disease phenotypes. Movement Disorders, 26(4):722–727, January 2011. URL: http://dx.doi.org/10.1002/mds.23452, doi:10.1002/mds.23452. This article has 17 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/mds.23452)

[5. (Guillemain2020LINGO) Anthony Guillemain, Yousra Laouarem, Laetitia Cobret, Dora Štefok, Wanyin Chen, Solal Bloch, Amina Zahaf, Lauren Blot, Flora Reverchon, Thierry Normand, Martine Decoville, Catherine Grillon, Elisabeth Traiffort, and Séverine Morisset‐Lopez. Lingo family receptors are differentially expressed in the mouse brain and form native multimeric complexes. The FASEB Journal, 34(10):13641–13653, August 2020. URL: http://dx.doi.org/10.1096/fj.202000826r, doi:10.1096/fj.202000826r. This article has 10 citations.](https://doi.org/10.1096/fj.202000826r)

[6. (Mi2004LINGO1) Sha Mi, Xinhua Lee, Zhaohui Shao, Greg Thill, Benxiu Ji, Jane Relton, Melissa Levesque, Norm Allaire, Steve Perrin, Bryan Sands, Thomas Crowell, Richard L Cate, John M McCoy, and R Blake Pepinsky. Lingo-1 is a component of the nogo-66 receptor/p75 signaling complex. Nature Neuroscience, 7(3):221–228, February 2004. URL: http://dx.doi.org/10.1038/nn1188, doi:10.1038/nn1188. This article has 679 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nn1188)

[7. (Mi2008LINGO1) Sha Mi, Alfred Sandrock, and Robert H. Miller. Lingo-1 and its role in cns repair. The International Journal of Biochemistry &amp; Cell Biology, 40(10):1971–1978, January 2008. URL: http://dx.doi.org/10.1016/j.biocel.2008.03.018, doi:10.1016/j.biocel.2008.03.018. This article has 77 citations.](https://doi.org/10.1016/j.biocel.2008.03.018)

[8. (Lee2007NGF) Xinhua Lee, Zhongshu Yang, Zhaohui Shao, Sheila S. Rosenberg, Melissa Levesque, R. Blake Pepinsky, Mengsheng Qiu, Robert H. Miller, Jonah R. Chan, and Sha Mi. Ngf regulates the expression of axonal lingo-1 to inhibit oligodendrocyte differentiation and myelination. The Journal of Neuroscience, 27(1):220–225, January 2007. URL: http://dx.doi.org/10.1523/jneurosci.4175-06.2007, doi:10.1523/jneurosci.4175-06.2007. This article has 139 citations.](https://doi.org/10.1523/jneurosci.4175-06.2007)

[9. (Shao2017LINGO1) Zhaohui Shao, Xinhua Lee, Guanrong Huang, Guoqing Sheng, Christopher E. Henderson, Daniel Louvard, Jiho Sohn, Blake Pepinsky, and Sha Mi. Lingo-1 regulates oligodendrocyte differentiation through the cytoplasmic gelsolin signaling pathway. The Journal of Neuroscience, 37(12):3127–3137, February 2017. URL: http://dx.doi.org/10.1523/JNEUROSCI.3722-16.2017, doi:10.1523/jneurosci.3722-16.2017. This article has 50 citations.](https://doi.org/10.1523/JNEUROSCI.3722-16.2017)

[10. (Andrews2015A) Jessica L. Andrews and Francesca Fernandez-Enright. A decade from discovery to therapy: lingo-1, the dark horse in neurological and psychiatric disorders. Neuroscience &amp; Biobehavioral Reviews, 56:97–114, September 2015. URL: http://dx.doi.org/10.1016/j.neubiorev.2015.06.009, doi:10.1016/j.neubiorev.2015.06.009. This article has 38 citations.](https://doi.org/10.1016/j.neubiorev.2015.06.009)